OpenVSafe by OpenVAERS
Search V-safe

3WU-25742-90003

2 vaccinations 4 coded responses 21 check-ins 4 free-text entries 5 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
452 / OH
Registered
2020-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Registered in v-safe
  2. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-21
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2020-12-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea, Sneezing — Feeling: Good
    Free text: Sneezing, runny nose x few days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-06
    Survey response — day 14, dose 1
    MedDRA: Dehydration, Headache, Hypotension, Migraine, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Hypotension, dehydration, migraine 1 day after blood donation. Headaches/possible migraine 3 consecutive days prior to blood donation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-06
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  11. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  12. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Decreased appetite — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work
    Free text: Axillary tenderness on same arm as injection; I forgot to report it yesterday. Decreased appetite.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-14
  16. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  17. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  19. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-01-20
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  21. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-13
  25. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-02-24
    Call successful
    Participant prefers to complete VAERS report online
  28. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Blister, Fatigue, Headache, Hypersensitivity, Injection site reaction, Nausea, Office visit, Pruritus, Urticaria — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Mild fatigue ongoing. Headache, injection site welt, nausea, and increased fatigue following Shingles vaccine 1/6/22. Developed new allergy to hormone replacement therapy patch last month: welt, blisters, itching, addressed by ObGyn.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-11
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-01-12
  33. 2022-01-14
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

5 call center cases

5 successful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-27

Systemic reaction (other): Sneezing, runny nose x few days

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Hypotension, dehydration, migraine 1 day after blood donation. Headaches/possible migraine 3 consecutive days prior to blood donation.

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Axillary tenderness on same arm as injection; I forgot to report it yesterday. Decreased appetite.

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Mild fatigue ongoing. Headache, injection site welt, nausea, and increased fatigue following Shingles vaccine 1/6/22. Developed new allergy to hormone replacement therapy patch last month: welt, blisters, itching, addressed by ObGyn.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlister · · ✓
SDDehydration ✓ ✓ ✓
SDFatigue · · ✓
SDHeadache ✓ ✓ ✓
SDHypersensitivity · · ✓
SDHypotension ✓ ✓ ✓
SDInjection site reaction · · ✓
SDMigraine ✓ ✓ ✓
SDNausea · · ✓
SDOffice visit · · ✓
SDPre-existing disease ✓ ✓ ✓
SDPruritus · · ✓
SDUrticaria · · ✓
SROAxillary pain ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROSneezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release